# Effect of Tamsulosin vs Prazosin in Treatment of Female Voiding Dysfunction

> **NCT00602186** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Tabriz University** · enrollment: 80 (actual)

## Conditions studied

- Neurogenic Bladder

## Interventions

- **DRUG:** tamsolusin
- **DRUG:** prazosin

## Key facts

- **NCT ID:** NCT00602186
- **Lead sponsor:** Tabriz University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-07
- **Primary completion:** 2007-03
- **Final completion:** 2008-03
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2008-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00602186

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00602186, "Effect of Tamsulosin vs Prazosin in Treatment of Female Voiding Dysfunction". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00602186. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*